Clik here to view.
Tela Bio raises $7.4m
Tela Bio raised $7.4 million in a new round of equity financing, according to an SEC filing posted this week. The company produces Ovitex reinforced bioscaffolds designed for hernia repair or abdominal...
View ArticleClik here to view.
Skyline Medical shareholders OK 3x share increase
Skyline Medical said today that its shareholders agreed to an amendment which would increase shares of common stock from 8 million to 24 million. The decision was made at a special meeting of...
View ArticleClik here to view.
Does your medical device and IVD sales need an import license in India?
By Stewart Eisenhart, Emergo Group India’s medical device registration system is still transitioning to a more formalized and predictable framework, which has raised questions from foreign...
View ArticleClik here to view.
FDA approves Gore’s Viabahn VBX stent graft for iliac artery lesions
W.L. Gore & Assoc. said today that it won FDA approval for its Viabahn VBX stent graft for treating iliac artery lesions, including those found at the aortic bifurcation. Flagstaff, Ariz.-based...
View ArticleClik here to view.
Pacemaker data lead to arson charges for Ohio man
Pacemaker data reportedly led to arson and fraud charges for an Ohio man accused of torching his home for the insurance money. Ross Compton of Middletown, Ohio, faces felony counts of aggravated arson...
View ArticleClik here to view.
Covidien spinout Mallinckrodt closes $690m sale of nuclear imaging biz
Covidien spinout Mallinckrodt plc (NYSE:MNK) said today that it closed the $690 million sale of its nuclear imaging business to IBA Molecular. Mallinckrodt’s nuclear imaging business includes 2...
View ArticleClik here to view.
Novo Nordisk puts $145m into U.K. research center
(Reuters) – Novo Nordisk, the world’s top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research center in Britain, undeterred by Brexit. The Danish company said on...
View ArticleClik here to view.
Zimmer Biomet logs 3rd win in NexGen Flex bellwether trials
Zimmer Biomet (NYSE:ZBH) last week won its 3rd bellwether trial in the multi-district litigation brought over the NexGen Flex knee implant, after a federal jury in Illinois found against the plaintiff....
View ArticleClik here to view.
Teva wins FDA nod for inhaled asthma medications
Teva Pharmaceuticals (NYSE:TEVA) said today that the FDA approved 2 inhaled asthma medications to be delivered using the company’s RespiClick breath-activated, multi-dose dry powder inhaler. The...
View ArticleClik here to view.
Pulmatrix seeks to raise $5m in direct offering
Pulmatrix (NSDQ:PULM) said today that it landed an agreement with several institutional investors to purchase $5.0 million of shares of common stock in a registered direct offering. The Lexington,...
View ArticleClik here to view.
Early research shows shark antibodies carrying drugs across blood-brain barrier
Photo credit: Albert Kok Danish pharmaceutical company Lundbeck made an undisclosed milestone payment to biotech Ossianix Inc., after experiments showed that shark antibodies effectively shuttled...
View ArticleClik here to view.
Volpara touts study showing benefits for density scanning before mammograms
Volpara Solutions today released results from a study of its Volpara Density measuring software, touting the benefits of the software for improving mammography performance measures. The study included...
View ArticleClik here to view.
BioSig seeks funding in the EU
BioSig Technologies (OTCQB: BSGM) said today it will engage in an institutional investor roadshow in the EU as it seeks funding for its proprietary Pure electrophysiology platform. The company is...
View ArticleClik here to view.
Hill-Rom shares dip on Q1 miss
Shares in Hill-Rom (NYSE:HRC) have dipped today after the company missed expectations on The Street with its 1st quarter earnings results. The Chicago-based company posted profits of $23.5 million, or...
View ArticleClik here to view.
Researchers develop immune cells that infiltrate tumors
Researchers from the Okayama University have developed a group of immune cells that can infiltrate tumors and deliver viral vectors, destroying them from the inside out. The team’s work was published...
View ArticleClik here to view.
Merck becomes latest to offer insight into drug pricing practices
Last week, Merck (NYSE:MRK) released figures about its U.S. pricing practices, joining a growing list of companies that are revealing their pricing strategies amid criticism of the industry’s price...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 30, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Varian Medical closes $600m Varex Imaging spinout
Varian Medical (NYSE:VAR) today announced it successfully completed the $600 million spin-out of its imaging components biz, Varex Imaging (NSDQ:VREX). Salt Lake City, Utah-based Varex Medical said...
View ArticleClik here to view.
HHS nominee Price facing more questions ahead of Senate panel vote
Rep. Tom Price (R-Ga.) is facing more questions about his stock deals, a day before a U.S. Senate panel is slated to vote on whether to approve his nomination to head the Health & Humans Services...
View ArticleClik here to view.
Metallic hydrogen could be a reality: Why you should care
Transparent molecular hydrogen (left) at about 200 GPa became black molecular hydrogen (center) and finally reflective atomic metallic hydrogen at 495 GPa (right). [Image courtesy of Isaac...
View Article